- Home
- HOWL vs NVNI Comparison
HOWL vs NVNI Comparison
Compare HOWL & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- NVNI
- Stock Information
- Founded
- HOWL 2017
- NVNI 2019
- Country
- HOWL United States
- NVNI Brazil
- Employees
- HOWL N/A
- NVNI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- NVNI
- Sector
- HOWL Health Care
- NVNI
- Exchange
- HOWL Nasdaq
- NVNI Nasdaq
- Market Cap
- HOWL 64.5M
- NVNI 57.2M
- IPO Year
- HOWL 2021
- NVNI N/A
- Fundamental
- Price
- HOWL $1.40
- NVNI $0.81
- Analyst Decision
- HOWL Strong Buy
- NVNI
- Analyst Count
- HOWL 5
- NVNI 0
- Target Price
- HOWL $7.20
- NVNI N/A
- AVG Volume (30 Days)
- HOWL 151.8K
- NVNI 2.7M
- Earning Date
- HOWL 11-06-2025
- NVNI 09-30-2025
- Dividend Yield
- HOWL N/A
- NVNI N/A
- EPS Growth
- HOWL N/A
- NVNI N/A
- EPS
- HOWL N/A
- NVNI N/A
- Revenue
- HOWL N/A
- NVNI $31,250,627.00
- Revenue This Year
- HOWL N/A
- NVNI $12.05
- Revenue Next Year
- HOWL N/A
- NVNI $15.02
- P/E Ratio
- HOWL N/A
- NVNI N/A
- Revenue Growth
- HOWL N/A
- NVNI 1491.58
- 52 Week Low
- HOWL $0.60
- NVNI $0.14
- 52 Week High
- HOWL $4.18
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- HOWL 56.16
- NVNI 69.81
- Support Level
- HOWL $1.38
- NVNI $0.52
- Resistance Level
- HOWL $1.49
- NVNI $0.57
- Average True Range (ATR)
- HOWL 0.07
- NVNI 0.06
- MACD
- HOWL 0.00
- NVNI 0.01
- Stochastic Oscillator
- HOWL 55.00
- NVNI 83.99
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.